BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $988,000 | – | 8,329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 857,494 | $55,746,000 | 45.68% |
| RP Management, LLC | 2,111,111 | $137,243,000 | 20.57% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,074,800 | $134,883,000 | 17.78% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,310,261 | $85,180,000 | 9.56% |
| TANG CAPITAL MANAGEMENT LLC | 599,091 | $38,947,000 | 7.05% |
| Blackcrane Capital, LLC | 44,112 | $2,868,000 | 6.69% |
| ARS Investment Partners, LLC | 559,574 | $36,378,000 | 5.72% |
| Eversept Partners, LP | 321,581 | $20,905,981 | 4.64% |
| Avidity Partners Management LP | 1,284,200 | $83,486,000 | 3.87% |
| ARDSLEY ADVISORY PARTNERS LP | 257,000 | $16,708,000 | 3.22% |